Your search returned 5 results.

Results
	1.	Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO. [electronic resource] by Sormani, Maria Pia Truffinet, Philippe Thangavelu, Karthinathan Rufi, Pascal Simonson, Catherine De Stefano, Nicola Publication details: Neurology(R) neuroimmunology & neuroinflammation Sep 2017 In: Neurology(R) neuroimmunology & neuroinflammation vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice. [electronic resource] by Coyle, Patricia K Khatri, Bhupendra Edwards, Keith R Meca-Lallana, José E Cavalier, Steve Rufi, Pascal Benamor, Myriam Thangavelu, Karthinathan Robinson, Miqun Gold, Ralf Producer: 20190228 In: Multiple sclerosis and related disorders vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study. [electronic resource] by Coyle, Patricia K Khatri, Bhupendra Edwards, Keith R Meca-Lallana, José E Cavalier, Steve Rufi, Pascal Benamor, Myriam Brette, Sandrine Robinson, Miqun Gold, Ralf Producer: 20180607 In: Multiple sclerosis and related disorders vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study. [electronic resource] by Coyle, Patricia K Khatri, Bhupendra Edwards, Keith R Meca-Lallana, José E Cavalier, Steve Rufi, Pascal Benamor, Myriam Poole, Elizabeth M Robinson, Miqun Gold, Ralf Producer: 20191223 In: Multiple sclerosis and related disorders vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD). [electronic resource] by Vukusic, Sandra Brassat, David de Seze, Jerome Izquierdo, Guillermo Lysandropoulos, Andreas Moll, Wibe Vanopdenbosch, Ludo Arque, Maria Jesus Kertous, Mehdi Rufi, Pascal Oreja-Guevara, Celia Producer: 20190716 In: Multiple sclerosis and related disorders vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)